News & Updates

Neoadjuvant chemohormonal therapy (NCHT) plus radical prostatectomy (RP) confers significant biochemical progression-free survival (bPFS) benefits relative to neoadjuvant hormonal therapy (NHT) plus RP on patients with high-risk, locally advanced prostate cancer, reports a study.

Men with prostate cancer who consume higher amounts of plant-based foods have a lower risk of cancer progression, as shown in a longitudinal observational cohort study.

A weight management intervention results in better body composition, quality of life, and prostate cancer (PCa) biomarkers in men scheduled for prostatectomy, reports a study.

Patients with complicated urinary tract infection (UTI) may fare better with cefepime–taniborbactam than with meropenem, with the combination having been associated with much higher treatment success rates in the phase III CERTAIN-1 trial.